Patient Education

Patient Education

Patient-focused tear sheets produced by ASH in collaboration with patient organizations

Understanding Blood Clots

As many as 900,000 people in the United States develop blood clots annually, and clots are responsible for approximately 100,000 deaths each year. Research has...

Navigating Clinical Trials

A clinical trial is a controlled research study conducted by doctors and medical researchers to improve the care and treatment of people who have...

Women and the Risk of Blood Clots

Nearly 900,000 people are affected by blood clots each year, leading to approximately 100,000 blood clot-related deaths annually. Dangerous blood clots such as deep-vein...

The Pediatric Patient Living With Sickle Cell Disease

Sickle cell disease (SCD) is the most common genetic disorder in the United States, with about 100,000 American who have the disease and another...

Understanding Bone and Blood Marrow Transplants

Bone marrow is the soft tissue inside the bones that makes blood-forming cells known as blood stem cells. These grow into red blood cells...

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) are cancers that affect the same lymphocytes, a type of white blood cell. CLL and...

What Is Acute Myeloid Leukemia?

Acute myeloid leukemia (AML) is the most common acute leukemia in the United States, comprising 33 percent of all leukemias. The cancer progresses rapidly...

Understanding Light Chain Amyloidosis

Amyloidosis is a rare disease that occurs due to a buildup of protein in different vital organs throughout the body. The disease is often...

Understanding Transplant in Lymphoma

Hematopoietic cell transplantation (HCT), also called stem cell or bone marrow transplantation, is a treatment option for patients with blood cancers such as leukemia,...

Understanding Mantle Cell Lymphoma

Lymphoma is the most common blood cancer. The two main forms of lymphoma are Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL). Mantle cell lymphoma...
Advertisement

Current Issue

July 2017, Volume 3, Issue 8

This issue features an interview with the FDA's Richard Pazdur, highlights from the 2017 ASCO Annual Meeting, a debate about minimal residual disease in myeloma, and more.